The National Institutes of Health is upgrading its drug development and manufacturing facility -- new location, new equipment, same mission -- to "help move ideas from the laboratory bench to the patient faster and better," said John Gallin, director of the NIH Clinical Center.
As I toured the new $12 million, over 1,000 square meter facility today (March 25), I meandered through room after room of new, top of the line equipment, high quality air filters, and easily cleanable epoxy flooring -- all aimed to better meet the US Food and Drug Administration's standards of good manufacturing practice (GMP). My tour comes just a few weeks after the NIH and FDA linkurl:announced a collaboration;http://www.the-scientist.com/blog/display/57174/ to increase efforts in translational and regulatory science. While the timing of the new partnership is purely "coincidental," Gallin said, the NIH did consult with...
Image: National Institutes of Health
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!